DNA Double-strand Break Repair in Cancer: A Path to Achieving Precision Medicine

Overview

Journal Int Rev Cell Mol Biol

Publisher Elsevier

Specialties Cell Biology
Molecular Biology

Date 2021 Sep 11

PMID 34507781

Citations 7

Authors

Taneisha Gillyard

Jamaine Davis

Affiliations

Soon will be listed here.

Abstract

The assessment of DNA damage can be a significant diagnostic for precision medicine. DNA double strand break (DSBs) pathways in cancer are the primary targets in a majority of anticancer therapies, yet the molecular vulnerabilities that underlie each tumor can vary widely making the application of precision medicine challenging. Identifying and understanding these interindividual vulnerabilities enables the design of targeted DSB inhibitors along with evolving precision medicine approaches to selectively kill cancer cells with minimal side effects. A major challenge however, is defining exactly how to target unique differences in DSB repair pathway mechanisms. This review comprises a brief overview of the DSB repair mechanisms in cancer and includes results obtained with revolutionary advances such as CRISPR/Cas9 and machine learning/artificial intelligence, which are rapidly advancing not only our understanding of determinants of DSB repair choice, but also how it can be used to advance precision medicine. Scientific innovation in the methods used to diagnose and treat cancer is converging with advances in basic science and translational research. This revolution will continue to be a critical driver of precision medicine that will enable precise targeting of unique individual mechanisms. This review aims to lay the foundation for achieving this goal.

Citing Articles

Mechanisms underlining R-loop biology and implications for human disease.

Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.

PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.

Deferasirox's Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma.

Delgado Y, Torres-Sanchez A, Perez D, Torres G, Estrada S, Ortiz Alvelo N Biomedicines. 2024; 12(10).

PMID: 39457585 PMC: 11505511. DOI: 10.3390/biomedicines12102272.

Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.

Nakauma-Gonzalez J, Rijnders M, Noordsij M, Martens J, van der Veldt A, Lolkema M Cell Genom. 2024; 4(4):100528.

PMID: 38552621 PMC: 11019362. DOI: 10.1016/j.xgen.2024.100528.

Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics.

Abou Ghayda R, Cannarella R, Calogero A, Shah R, Rambhatla A, Zohdy W World J Mens Health. 2023; 42(1):39-61.

PMID: 37382282 PMC: 10782130. DOI: 10.5534/wjmh.230050.

Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy.

Pismataro M, Astolfi A, Letizia Barreca M, Pacetti M, Schenone S, Bandiera T J Med Chem. 2023; 66(10):6498-6522.

PMID: 37134182 PMC: 10226047. DOI: 10.1021/acs.jmedchem.2c02101.

References

Sharma P, Ponnaiya B, Taveras M, Shuryak I, Turner H, Brenner D . High throughput measurement of γH2AX DSB repair kinetics in a healthy human population. PLoS One. 2015; 10(3):e0121083. PMC: 4368624. DOI: 10.1371/journal.pone.0121083. View

Khanna K, Jackson S . DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001; 27(3):247-54. DOI: 10.1038/85798. View

Aly A, Ganesan S . BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. J Mol Cell Biol. 2011; 3(1):66-74. PMC: 3030974. DOI: 10.1093/jmcb/mjq055. View

Sharma A, Singh K, Almasan A . Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol. 2012; 920:613-26. DOI: 10.1007/978-1-61779-998-3_40. View

Roidos P, Sungalee S, Benfatto S, Sercin O, Stutz A, Abdollahi A . A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice. Nat Commun. 2020; 11(1):4077. PMC: 7429917. DOI: 10.1038/s41467-020-17962-3. View

Corneo B, Wendland R, Deriano L, Cui X, Klein I, Wong S . Rag mutations reveal robust alternative end joining. Nature. 2007; 449(7161):483-6. DOI: 10.1038/nature06168. View

Hart S, Polley E, Shimelis H, Yadav S, Couch F . Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML. NPJ Breast Cancer. 2020; 6:13. PMC: 7190647. DOI: 10.1038/s41523-020-0159-x. View

Bennardo N, Cheng A, Huang N, Stark J . Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008; 4(6):e1000110. PMC: 2430616. DOI: 10.1371/journal.pgen.1000110. View

Ciszewski W, Tavecchio M, Dastych J, Curtin N . DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res Treat. 2013; 143(1):47-55. DOI: 10.1007/s10549-013-2785-6. View

10.

Mehta A, Haber J . Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2014; 6(9):a016428. PMC: 4142968. DOI: 10.1101/cshperspect.a016428. View

11.

Taylor E, Cecillon S, Bonis A, Chapman J, Povirk L, Lindsay H . The Mre11/Rad50/Nbs1 complex functions in resection-based DNA end joining in Xenopus laevis. Nucleic Acids Res. 2009; 38(2):441-54. PMC: 2811014. DOI: 10.1093/nar/gkp905. View

12.

Mao Z, Bozzella M, Seluanov A, Gorbunova V . Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst). 2008; 7(10):1765-71. PMC: 2695993. DOI: 10.1016/j.dnarep.2008.06.018. View

13.

. BRCA Exchange Launches. Cancer Discov. 2019; 9(3):311-312. DOI: 10.1158/2159-8290.CD-NB2019-008. View

14.

Zha S, Boboila C, Alt F . Mre11: roles in DNA repair beyond homologous recombination. Nat Struct Mol Biol. 2009; 16(8):798-800. DOI: 10.1038/nsmb0809-798. View

15.

Rothkamm K, Kruger I, Thompson L, Lobrich M . Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 2003; 23(16):5706-15. PMC: 166351. DOI: 10.1128/MCB.23.16.5706-5715.2003. View

16.

Sung P, Klein H . Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Nat Rev Mol Cell Biol. 2006; 7(10):739-50. DOI: 10.1038/nrm2008. View

17.

Syed A, Tainer J . The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair. Annu Rev Biochem. 2018; 87:263-294. PMC: 6076887. DOI: 10.1146/annurev-biochem-062917-012415. View

18.

Comen E, Robson M . Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J. 2010; 16(1):48-52. PMC: 4035043. DOI: 10.1097/PPO.0b013e3181cf01eb. View

19.

Bonner W, Redon C, Dickey J, Nakamura A, Sedelnikova O, Solier S . GammaH2AX and cancer. Nat Rev Cancer. 2008; 8(12):957-67. PMC: 3094856. DOI: 10.1038/nrc2523. View

20.

Tutt A, Ashworth A . The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med. 2002; 8(12):571-6. DOI: 10.1016/s1471-4914(02)02434-6. View